Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The emerging role of academia in commercializing innovation

Nature Biotechnology volume 22, pages 21–24 (2004)Cite this article

The university has been slowly changing from ivory tower to economic engine. Publicly funded research organizations are becoming increasingly adept at protecting intellectual property (IP), spinning out new companies, licensing technology to the private sector and even developing their own venture arms to finance commercial development of their discoveries. The migration of universities into more translational research will likely enhance their ability to capitalize on IP assets and ultimately could reduce the internal cost of producing new medicines

Corporate academia

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. http://www.autm.net/

  2. Casper, S. & Kettler, H. Industry Innovation 8, 5–30 (April 2001).

    Article  Google Scholar 

  3. Triendl, R. Res. Technol. Management 42, 5–7 (Mar/Apr 1999).

    Google Scholar 

  4. Feldman, M. et al. Management Sci. 48, 105–121 (2002).

    Article  Google Scholar 

  5. Press, E. & Washburn, J. Atl. Mon. 285, 39–54 (March 2000).

    Google Scholar 

  6. Munro, N. Natl. J. 580–585 (22 February, 2003).

  7. Cohen, W.M., Florida, R., Randazzese, L. & Walsh, J. in Challenges to Research Universities (ed. R. Noll) 171–199 (Brookings Institution Press, Washington, DC, 1998).

    Google Scholar 

  8. Pressman, L. (ed.). AUTM Licensing Survey: FY 2001 Survey Summary (AUTM, Northbrook, Il, USA, 2003) (http://www.autm.net/surveys/01/ 01summarypublicversion.pdf ).

  9. http://www.nibib.nih.gov/

  10. Pulley, J. Chronicle Higher Edu. 49, A23 (January 24, 2003).

    Google Scholar 

  11. Basinger, J. Chronicle Higher Edu. 49, A32 (December 13, 2002).

    Google Scholar 

  12. Barker, E. Inc. Magazine, p. 66 (November, 2002).

    Google Scholar 

  13. Tornatzky, L.G., Waugaman, P.G. & Gray, D.O. Innovation University: New University Roles In A Knowledge Economy (Southern Technology Council and Southern Growth Policies Board, Research Triangle Park, NC, 2002).

    Google Scholar 

  14. DiMasi, J.A., Hansen, R.W. & Grabowski, H.G. J. Health Economics 22, 151–185 (2003).

    Article  Google Scholar 

  15. The Pharmaceutical Research and Manufacturers of America. New Drug Approvals in 2001 (PhRMA, Washington, DC, USA) p. 17 (January 2002) (http://www.phrma.org/newmedicines/ resources/2002-01-25.46.pdf).

  16. Guyer, R.L. People doing science (NIH, Bethseda, MD, USA) (http://www4.od.nih.gov/officeofbudget/FY04pub/ MechanismTotal.PDF)

  17. Department of Health and Human Services. NIH Response to the Conference Report Request for a Plan to Ensure Taxpayers' Interests are Protected (NIH, Bethseda, MD, USA) (July 2001) (http://www.nih.gov/news/070101wyden.htm).

  18. Pollack, A. UCSD getting more involved in drug trials. SignOnSanDiego.com, 31 July 2003 (http://www.signonsandiego.com/news/business/ biotech/20030731-9999_1b31biotech.html).

  19. Gwynne, P. Drug Disc. Dev., p. 81 (October 1, 2002).

  20. Kalorama Information. Outsourcing in Drug Discovery (Kalorama Information, New York, NY, USA, 2003).

  21. Waltham, M.M. (ed.). Parexel's Pharmaceutical R&D Statistical Sourcebook. p. 25 (Parexel International Corporation, Waltham, MA, USA, 2001).

    Google Scholar 

  22. GlaxoSmithKline. GlaxoSmithKline unveils strategy for growth (GSK, Brentford, UK) (February 22, 2001) (http://www.gsk.com/press_archive/press_02222001.htm).

  23. Dyer, G. Financial Times, p. 19, London edn, (January 25, 2002).

    Google Scholar 

  24. Baltimore, D. et al. US Patent 6,410,516 (issued June 25, 2002).

  25. Young, D.A. et al. US Patent 6,048,850 (issued April 11, 2000).

  26. Shulman, S. MIT Technol. Rev. 106, 75 (2003).

    Google Scholar 

  27. Russo, E. The Scientist, 14, 8 (2000).

    Google Scholar 

  28. Rai, A.K. & Eisenberg, R.S. Law Contemp. Problems 66, 289 (2003).

    Google Scholar 

  29. Rai, A.K. & Eisenberg, R.S. Am. Sci. 91, 52 (2003).

    Article  Google Scholar 

  30. Agres, T. The Scientist 17, 58–59 (2003).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lally School of Management and Technology, Rensselaer Polytechnic Institute, 110 Eighth St., Troy, 12180, New York, USA

    Shreefal Mehta

Authors
  1. Shreefal Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehta, S. The emerging role of academia in commercializing innovation. Nat Biotechnol 22, 21–24 (2004). https://doi.org/10.1038/nbt0104-21

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0104-21

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing